ε-polylysine inhibits pancreatic lipase activity and suppresses postprandial hypertriacylglyceridemia in rats

Journal of Nutrition

Volumn 133, Issue 6, 2003, Pages 1887-1891

  Kido, Yasuhiro ^b   Hiramoto, Shigeru ^a   Murao, Miyuki ^b   Horio, Yoko ^b   Miyazaki, Toshiyuki ^a   Kodama, Toshiaki ^a   Nakabou, Yukihiro ^b  

^a Health Care Research Center   (Japan)

^b NONE

Author keywords

Emulsion breakdown activity; Hypotriacylglyceridemic activity; Lipase inhibitory activity; Rats; polylysine

Indexed keywords

BILE SALT; CHOLESTEROL; CHYMOTRYPSIN; EPSILON POLYLYSINE; FOOD ADDITIVE; GUM ARABIC; PEPSIN A; PHOSPHATIDYLCHOLINE; PHOSPHOLIPID; POLYLYSINE; POLYVINYL ALCOHOL; TRIACYLGLYCEROL; TRIACYLGLYCEROL LIPASE; TRYPSIN; UNCLASSIFIED DRUG; ENZYME INHIBITOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; EMULSION; ENZYME INHIBITION; HUMAN; HYPERTRIGLYCERIDEMIA; LIPID ABSORPTION; MALE; NONHUMAN; OBESITY; POLYMERIZATION; POSTPRANDIAL STATE; RAT; SWINE; TRIACYLGLYCEROL BLOOD LEVEL; ANIMAL; BLOOD; DRUG ANTAGONISM; ENZYMOLOGY; OSMOLARITY; PANCREAS; SPRAGUE DAWLEY RAT;

ACACIA SENEGAL; ANIMALIA; SUIDAE; SUS SCROFA;

ANIMALS; ENZYME INHIBITORS; HYPERTRIGLYCERIDEMIA; LIPASE; MALE; OSMOLAR CONCENTRATION; PANCREAS; POLYLYSINE; POSTPRANDIAL PERIOD; RATS; RATS, SPRAGUE-DAWLEY; TRIGLYCERIDES;

EID: 0038314476     PISSN: 00223166     EISSN: None     Source Type: Journal    
DOI: 10.1093/jn/133.6.1887     Document Type: Article

References (19)

1. Hill, J. O., Melansonand, E. L. & Wyatt, H. (2000) Dietary fat intake and regulation of energy balance: implications for obesity. J. Nutr. 130: 284S-288S.
2. Golay, A. & Bobbioni, E. (1997) The role of dietary fat in obesity. Int. J. Obes. Relat. Metab. Disord. 21: S2-S11.
3. Bray, G. A. & Popkin, B. M. (1998) Dietary fat intake does affect obesity! Am. J. Clin. Nutr. 68: 1157-1173.
4. Drewnowski, A., Kurth, C., Holden-Wiltse, J. & Saari, J. (1992) Food preferences in human obesity: carbohydrates versus fats. Appetite 18: 207-221.
5. Duan, R. D. (2000) Enzymatic aspects of fat digestion in the gastrointestinal tract. In: Fat Digestion and Absorption (Christophe, A. B. & Vriese, S., eds.), pp. 25-46, AOCS Press, Champaign, IL.
6. Noda, K., Sakurai, T., Takahashi, M., Aiuchi, M. & Ohgushi, M. (1999) Two-generation reproduction study with teratology test of ε-poly-L-lysine by dietary administration in rats. Yakuri To Chiryo (Jpn. J. Pharmacol.Ther.) 27: 1139-1159.
7. Fukutome, A., Kashima, M., Shirai, M. & Siuchi, M. (1995) A combined chronic toxicity and carcinogenicity study of ε-polylysine in the rat. Clin. Rep. 29: 66-84.
8. Mansbach, C., Cohen, R. & Leff, P. (1975) Isolation and properties of the mixed lipid micelles present in intestinal content during fat digestion in man. J. Clin. Investig. 56: 781-791.
9. Duncombe, W. G. (1963) The colorimetric micro-determination of long-chain fatty salts. Biochem. J. 88: 7-10.
10. Jackman, R. L., Yada, R. Y. & Paulson, A. L. (1989) Characterization of kinetics of breakdown of protein stabilized oil in water emulsions. J. Agric. Food Chem. 37: 600-604.
11. Wolever, T., Jenkinsand, A. & Josse, R. (1991) The glycemic index: methodology and clinical applications. Am. J. Clin. Nutr. 54: 846-854.
12. Shima, S. & Sakai, H. (1981) Poly-L-lysine produced by Streptomyces. Part II. Taxonomy and fermentation studies. Agric. Biol. Chem. 45: 2497-2502.
13. Shima, S. & Sakai, H. (1981) Poly-L-lysine produced by Streptomyces. Part III. Chemical studies. Agric. Biol. Chem. 45: 2503-2508.
14. Shima, S., Matsuoka, H., Iwamoto, T. & Sakai, H. (1984) Antimicrobial action of ε-poly-L-lysine. J. Antibiot. 37: 1449-1455.
15. Shima, S., Fukuhara, Y. & Sakai, H. (1982) Inactivation of bacteriophages by ε-poly-L-lysine produced by Streptomyces. Agric. Biol. Chem. 46: 1917-1919.
16. Tsujita T., Matsuura, Y. & Okuda, H. (1996) Studies on the inhibition of pancreatic and carboxylester lipases by protamine. J. Lipid Res. 37: 1481-1487.
17. Thompson, G. R., Barrowman, J., Gutierrez, L. & Dowling, R. H. (1971) Action of neomycin on the intraluminal phase of lipid absorption. J. Clin. Investig. 50: 319-323.
18. Hoeg, J. M., Maher, M. B., Bailey, K. R. & Brewe, H. B., Jr. (1986) The effects of mevinolin and neomycin alone and in combination on plasma lipid and lipoprotein concentrations in type II hyperlipoproteinemia. Atherosclerosis 60: 209-214.
19. Farnsworth, W. H., Hoeg, J. M., Maher, E. H., Sherins, R. J. & Brewer, Jr. H.B. (1987) Testicular function in type II hyperlipoproteinemic patients treated with lovastatin (mevinolin) or neomycin. J. Clin. Endocrinol. Metab. 65: 546-550.